Okamet GM 1002 Tablet is a combination oral antidiabetic medicine manufactured by Cipla Ltd. It contains Glimepiride 2mg and Metformin Hydrochloride 1000mg (Sustained Release). This combination is widely prescribed for the management of Type 2 Diabetes Mellitus, especially when diet, exercise, and single-drug therapy are not enough to control blood sugar.
How Okamet GM 1002 Works
-
Glimepiride (2mg): Belongs to the sulfonylurea class. It stimulates the pancreas to release more insulin, thereby reducing blood glucose levels, especially after meals.
-
Metformin SR (1000mg): A biguanide that works by reducing sugar production in the liver, decreasing sugar absorption from the intestines, and improving the body’s response to insulin. The sustained-release form ensures gradual absorption, providing long-lasting sugar control with fewer stomach-related side effects.
Together, these two medicines provide synergistic action for better control of both fasting and postprandial (after meal) blood glucose levels.
Uses of Okamet GM 1002 Tablet
-
Treatment of Type 2 Diabetes Mellitus in patients not controlled by lifestyle measures or single therapy.
-
Helps in controlling both fasting and post-meal sugar levels.
-
Reduces the risk of long-term complications such as:
-
Kidney damage (diabetic nephropathy)
-
Nerve problems (diabetic neuropathy)
-
Eye damage (diabetic retinopathy)
-
Heart disease and stroke
-
May help in achieving better weight control compared to sulfonylurea alone.
Dosage & Administration
-
Usually taken once daily with meals, preferably breakfast or the first main meal.
-
Should be swallowed whole with water (do not crush or chew).
-
Dosage is individualized based on blood sugar levels and doctor’s advice.
-
Regular monitoring of blood glucose and HbA1c is necessary.
Precautions
-
Not recommended in Type 1 Diabetes or diabetic ketoacidosis.
-
Use cautiously in patients with kidney or liver problems.
-
Avoid alcohol intake, as it increases the risk of lactic acidosis (from Metformin) and severe hypoglycemia (from Glimepiride).
-
Hypoglycemia risk is higher, so patients should not skip meals and must carry a sugar source (glucose tablets/candy).
-
Pregnant or breastfeeding women should take only on doctor’s advice.
Possible Side Effects
-
Hypoglycemia (sweating, shakiness, dizziness, hunger, weakness)
-
Gastrointestinal issues (nausea, diarrhea, stomach discomfort)
-
Headache or dizziness
-
Rare: Vitamin B12 deficiency with long-term Metformin use
-
Rare but serious: Lactic acidosis with Metformin
Overall Benefit
Okamet GM 1002 Tablet provides a powerful dual therapy for Type 2 Diabetes by combining Glimepiride and Metformin. It ensures strong blood sugar control throughout the day, lowers the risk of diabetes-related complications, and supports better quality of life in patients who require combination treatment.
Okamet GM 501 Tablet is an oral antidiabetic combination medicine manufactured by Cipla Ltd. It combines Glimepiride 1mg and Metformin Hydrochloride 500mg (Sustained Release) to provide effective management of Type 2 Diabetes Mellitus in patients who are not adequately controlled with lifestyle modifications or single-drug therapy.
How Okamet GM 501 Works
-
Glimepiride (1mg): A sulfonylurea drug that stimulates the pancreas to release more insulin, thereby reducing high blood sugar levels after meals.
-
Metformin SR (500mg): A biguanide that reduces sugar production in the liver, decreases absorption of glucose from the intestine, and improves insulin sensitivity. The sustained-release formulation ensures gradual absorption, reducing stomach-related side effects and maintaining steady blood sugar control.
This dual mechanism targets both fasting and post-meal blood glucose levels, providing more comprehensive management of diabetes.
Uses of Okamet GM 501 Tablet
-
Treatment of Type 2 Diabetes Mellitus when diet, exercise, and monotherapy are insufficient.
-
Helps lower fasting and postprandial blood glucose levels.
-
Reduces the risk of long-term complications of diabetes such as:
-
Diabetic nephropathy (kidney damage)
-
Diabetic neuropathy (nerve pain, tingling, numbness)
-
Diabetic retinopathy (eye damage/vision loss)
-
Cardiovascular diseases (heart attack, stroke)
-
Provides better control in patients requiring combination therapy at lower Glimepiride strength.
Dosage & Administration
-
Usually taken once daily with a meal, preferably breakfast or the first main meal.
-
Swallow the tablet whole with water, do not crush or chew.
-
Dosage may be adjusted based on blood glucose levels and doctor’s recommendation.
-
Regular monitoring of blood sugar and HbA1c is advised.
Precautions
-
Not for use in Type 1 Diabetes or diabetic ketoacidosis.
-
Use cautiously in patients with kidney or liver impairment.
-
Avoid alcohol as it increases the risk of lactic acidosis (from Metformin) and severe hypoglycemia (from Glimepiride).
-
Hypoglycemia is possible; patients should not skip meals and should carry a sugar source (like glucose tablets or candy).
-
Use in pregnancy or breastfeeding should be done only under medical advice.
Possible Side Effects
-
Hypoglycemia (sweating, shakiness, dizziness, weakness)
-
Nausea, diarrhea, stomach upset
-
Headache, mild dizziness
-
Long-term Metformin use may lead to Vitamin B12 deficiency
-
Rare but serious: Lactic acidosis with Metformin
Overall Benefit
Okamet GM 501 Tablet is an effective and well-balanced therapy for Type 2 Diabetes, especially suitable for patients who need combination treatment but with a lower Glimepiride dose. It provides strong glucose control, reduces the risk of complications, and improves overall health outcomes when used along with diet and exercise.
Okamet GM 502 Tablet is a combination oral antidiabetic medicine manufactured by Cipla Ltd. It contains Glimepiride 2mg and Metformin Hydrochloride 500mg (Sustained Release). This medicine is prescribed for the management of Type 2 Diabetes Mellitus when diet, exercise, and single therapy are not sufficient to control blood sugar levels.
How Okamet GM 502 Works
-
Glimepiride (2mg): A sulfonylurea that stimulates the pancreas to release more insulin, helping to reduce high blood sugar levels, especially after meals.
-
Metformin SR (500mg): A biguanide that reduces glucose production in the liver, delays absorption of sugar from the intestine, and enhances the body’s sensitivity to insulin. The sustained-release (SR) formulation provides longer-lasting action and reduces stomach irritation compared to immediate-release forms.
Together, these medicines provide complementary effects, giving effective control over both fasting and postprandial (after meal) blood glucose levels.
Uses of Okamet GM 502 Tablet
-
Management of Type 2 Diabetes Mellitus in patients not adequately controlled by lifestyle measures or single-drug therapy.
-
Helps in lowering fasting and post-meal sugar levels.
-
Prevents the risk of diabetes-related long-term complications such as:
-
Diabetic kidney disease (nephropathy)
-
Nerve damage (neuropathy – tingling, numbness, burning pain)
-
Eye damage (retinopathy/vision problems)
-
Cardiovascular diseases such as heart attack and stroke
-
Beneficial for patients requiring stronger glucose control with higher Glimepiride strength.
Dosage & Administration
-
Usually taken once daily with the first main meal of the day (preferably breakfast).
-
Swallow the tablet whole with water; do not crush or chew.
-
Dose adjustments depend on blood sugar levels and doctor’s recommendation.
-
Regular monitoring of blood glucose and HbA1c is necessary for effective control.
Precautions
-
Not for use in Type 1 Diabetes or diabetic ketoacidosis.
-
Caution required in patients with kidney or liver problems.
-
Avoid alcohol as it increases the risk of hypoglycemia (low blood sugar) and lactic acidosis.
-
Patients should not skip meals and should always carry a sugar source (like glucose tablets or candy) in case of hypoglycemia.
-
Should be used during pregnancy or breastfeeding only on medical advice.
Possible Side Effects
-
Hypoglycemia (sweating, shakiness, hunger, dizziness, weakness)
-
Stomach upset, nausea, diarrhea, or abdominal discomfort
-
Headache or mild dizziness
-
Long-term use may cause Vitamin B12 deficiency (due to Metformin)
-
Rare but serious: Lactic acidosis (symptoms: muscle pain, breathing difficulty, severe weakness)
Overall Benefit
Okamet GM 502 Tablet provides a powerful dual therapy for Type 2 Diabetes by combining Glimepiride and Metformin SR. It ensures effective blood sugar control throughout the day, lowers the risk of diabetes-related complications, and improves overall quality of life when taken along with a proper diet and exercise routine.
Okamet GMP 1 Tablet is a triple combination oral antidiabetic medicine manufactured by Cipla Ltd. It contains Glimepiride 1mg, Metformin Hydrochloride 500mg (Sustained Release), and Pioglitazone 15mg. This medicine is prescribed for the management of Type 2 Diabetes Mellitus when diet, exercise, and dual therapy do not provide adequate control.
How Okamet GMP 1 Works
-
Glimepiride (1mg): A sulfonylurea that increases insulin secretion from the pancreas, lowering blood glucose after meals.
-
Metformin SR (500mg): A biguanide that reduces glucose production in the liver, delays sugar absorption from the intestines, and enhances insulin sensitivity in the body.
-
Pioglitazone (15mg): A thiazolidinedione that improves the body’s response to insulin, allowing better glucose utilization in muscles and fat tissues.
Together, these three medicines act through different mechanisms to provide powerful and comprehensive blood sugar control, targeting both fasting and postprandial (after meal) glucose levels.
Uses of Okamet GMP 1 Tablet
-
Management of Type 2 Diabetes Mellitus in patients not adequately controlled with diet, exercise, and dual therapy.
-
Helps in controlling fasting and post-meal sugar levels.
-
Prevents or delays complications of uncontrolled diabetes such as:
-
Diabetic neuropathy (nerve damage causing tingling, numbness, burning sensation)
-
Diabetic nephropathy (kidney damage leading to protein in urine)
-
Diabetic retinopathy (eye damage and vision loss)
-
Cardiovascular diseases (heart attack, stroke)
-
Provides strong control for patients requiring triple-drug therapy.
Dosage & Administration
-
Usually taken once daily with a main meal, preferably breakfast.
-
Swallow the tablet whole with water; do not crush or chew.
-
Dose is individualized based on blood glucose levels and doctor’s advice.
-
Regular monitoring of blood sugar, HbA1c, kidney and liver function tests is necessary.
Precautions
-
Not suitable for Type 1 Diabetes or diabetic ketoacidosis.
-
Use cautiously in patients with heart failure, liver disease, or kidney problems (due to Pioglitazone and Metformin).
-
Avoid alcohol as it increases the risk of lactic acidosis and severe hypoglycemia.
-
May cause fluid retention or weight gain (due to Pioglitazone).
-
Should be used in pregnancy or breastfeeding only under strict medical supervision.
Possible Side Effects
-
Hypoglycemia (sweating, dizziness, hunger, weakness)
-
Stomach upset, nausea, diarrhea (from Metformin)
-
Weight gain, fluid retention, or ankle swelling (from Pioglitazone)
-
Headache or dizziness
-
Rare but serious: Lactic acidosis, liver dysfunction, or worsening of heart failure
Overall Benefit
Okamet GMP 1 Tablet offers a triple mechanism of action by combining Glimepiride, Metformin SR, and Pioglitazone, making it highly effective in controlling Type 2 Diabetes when dual therapy is insufficient. It helps maintain stable sugar levels throughout the day, reduces the risk of long-term complications, and supports improved overall health and quality of life.
Okamet GMP 2 Tablet is a triple-drug oral antidiabetic formulation manufactured by Cipla Ltd. It contains Glimepiride 2mg, Metformin Hydrochloride 500mg (Sustained Release), and Pioglitazone 15mg. This medicine is prescribed to patients with Type 2 Diabetes Mellitus whose blood glucose is not adequately controlled with dual therapy or lifestyle modifications alone.
It provides comprehensive glycemic control by targeting different pathways responsible for high blood sugar, making it highly effective for long-term diabetes management.
How Okamet GMP 2 Works
-
Glimepiride (2mg): A sulfonylurea that stimulates the pancreas to release more insulin, thereby reducing high blood sugar after meals.
-
Metformin SR (500mg): A biguanide that lowers glucose production in the liver, delays intestinal absorption of sugar, and improves insulin sensitivity.
-
Pioglitazone (15mg): A thiazolidinedione that enhances the body’s response to insulin and improves glucose uptake in muscles and fat tissues.
This three-way mechanism ensures effective control of both fasting and postprandial (after-meal) blood glucose levels.
Uses of Okamet GMP 2 Tablet
-
Management of Type 2 Diabetes Mellitus in adults.
-
Helps control fasting and post-meal blood sugar levels.
-
Prevents the risk of diabetes-related complications such as:
-
Neuropathy (nerve damage)
-
Nephropathy (kidney damage)
-
Retinopathy (eye damage)
-
Cardiovascular complications (heart disease, stroke).
-
Useful for patients needing triple-drug therapy when single or dual drug therapy is not enough.
Dosage & Administration
-
Usually taken once daily with a meal (preferably breakfast or as directed by doctor).
-
Swallow whole with water; do not crush or chew.
-
Dose is individualized based on blood glucose levels and patient’s response.
-
Regular monitoring of blood sugar, HbA1c, kidney, and liver function is essential.
Precautions
-
Not for Type 1 Diabetes or diabetic ketoacidosis.
-
Caution in patients with heart failure, kidney or liver impairment.
-
Avoid alcohol (increases risk of lactic acidosis and hypoglycemia).
-
May cause weight gain and fluid retention (due to Pioglitazone).
-
Not recommended during pregnancy or breastfeeding unless advised by a doctor.
Possible Side Effects
-
Hypoglycemia (sweating, tremors, dizziness, weakness, hunger)
-
Gastrointestinal upset: nausea, vomiting, diarrhea (from Metformin)
-
Weight gain, fluid retention, ankle swelling (from Pioglitazone)
-
Headache or dizziness
-
Rare but serious: Lactic acidosis, liver dysfunction, or worsening of heart failure
Overall Benefit
Okamet GMP 2 Tablet provides a powerful triple-action therapy for effective control of Type 2 Diabetes. By combining Glimepiride, Metformin SR, and Pioglitazone, it helps achieve stable blood sugar control, reduces long-term diabetes complications, and improves the overall quality of life for patients needing intensive management.
Olmezest 20 Tablet is a prescription medicine used for the management of high blood pressure (hypertension). It contains Olmesartan Medoxomil (20mg), an angiotensin II receptor blocker (ARB) that relaxes blood vessels, lowers blood pressure, and improves blood flow, reducing the risk of heart attack, stroke, and kidney damage.
Uses:
-
Treatment of hypertension to lower elevated blood pressure
-
Reduces risk of cardiovascular complications in patients with high blood pressure
-
Helps protect kidneys in patients with type 2 diabetes and hypertension
How to Use:
-
Take the tablet orally as prescribed by your doctor, usually once daily.
-
Can be taken with or without food.
-
Swallow whole with water.
Dosage:
Precautions:
-
Inform your doctor if you have kidney disease, liver disease, or heart problems.
-
Avoid potassium supplements or salt substitutes containing potassium unless prescribed.
-
Use with caution during pregnancy and breastfeeding.
-
Monitor blood pressure regularly.
Possible Side Effects:
-
Dizziness, headache, or fatigue
-
Mild gastrointestinal discomfort
-
Rare: severe allergic reactions, kidney impairment, or low blood pressure
Oxra 10mg Tablet contains Dapagliflozin (10mg), a medicine belonging to the class of sodium-glucose co-transporter-2 (SGLT2) inhibitors. It is primarily used to manage type 2 diabetes mellitus by lowering high blood sugar levels. It works by helping the kidneys remove excess glucose from the bloodstream through urine. Apart from controlling blood sugar, it may also provide benefits in reducing the risk of heart failure and protecting kidney health in diabetic patients.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps reduce risk of hospitalization for heart failure in diabetic patients
-
May help in protecting kidney function in chronic kidney disease
How to Use:
Take the tablet as advised by your doctor, usually once daily. Swallow whole with water, with or without food. Maintain a proper diet and exercise routine along with this medicine.
Dosage:
The dose depends on your health condition, blood sugar levels, and response to treatment. Do not stop or change the dose without consulting your doctor.
Precautions:
-
Not recommended for type 1 diabetes or diabetic ketoacidosis.
-
Inform your doctor if you have kidney, liver, or urinary tract problems.
-
Maintain proper hydration as this medicine increases urine output.
-
Use with caution during pregnancy and breastfeeding.
-
Monitor blood sugar regularly.
Side Effects:
-
Frequent urination, increased thirst
-
Low blood sugar (when combined with other anti-diabetic medicines)
-
Urinary tract infections, genital infections
-
Dizziness, dehydration
-
Low blood pressure in some patients
Oxra 5mg Tablet contains Dapagliflozin (5mg), an SGLT2 (sodium-glucose co-transporter-2) inhibitor used for the management of type 2 diabetes mellitus. It works by promoting the removal of excess glucose from the body through urine, thereby lowering blood sugar levels. This medicine, when combined with proper diet and exercise, helps improve glycemic control and may also reduce the risk of heart failure and kidney complications in diabetic patients.
Uses:
-
Management of type 2 diabetes mellitus
-
May reduce the risk of heart failure hospitalization in diabetic patients
-
Offers kidney protection in certain chronic kidney disease patients
How to Use:
Take the tablet once daily as prescribed by your doctor. Swallow it whole with water, with or without food. Follow your recommended diet and exercise plan for best results.
Dosage:
The dosage depends on your blood sugar levels, health condition, and response to treatment. Do not alter or discontinue the dose without medical advice.
Precautions:
-
Not suitable for type 1 diabetes or diabetic ketoacidosis.
-
Inform your doctor if you have kidney or liver problems.
-
Maintain proper fluid intake to avoid dehydration.
-
Use with caution during pregnancy and breastfeeding.
-
Monitor your blood sugar levels regularly.
Side Effects:
-
Increased urination, excessive thirst
-
Urinary tract infections, genital infections
-
Low blood sugar (especially with insulin or other diabetes medicines)
-
Dizziness, dehydration
-
Low blood pressure in some cases
Oxra S 10mg/100mg Tablet is a combination of Dapagliflozin (10mg) and Sitagliptin (100mg), used for the effective management of type 2 diabetes mellitus. This dual therapy helps improve blood sugar control when diet, exercise, and single-agent treatment are not sufficient.
-
Dapagliflozin is an SGLT2 inhibitor that lowers blood sugar by removing excess glucose through urine.
-
Sitagliptin is a DPP-4 inhibitor that increases incretin hormone levels, boosting insulin release and reducing sugar production by the liver.
Together, they work in different ways to help maintain stable blood glucose levels and reduce the risk of diabetes-related complications.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps achieve better glycemic control when monotherapy is inadequate
-
May provide additional heart and kidney protection in diabetic patients
How to Use:
Take the tablet exactly as prescribed by your doctor, usually once daily. Swallow it whole with water, with or without food. Continue with your recommended diet and exercise plan for maximum benefit.
Dosage:
The dosage is individualized based on blood sugar levels, health condition, and prior response to diabetes medicines. Do not skip or stop without consulting your doctor.
Precautions:
-
Not for use in type 1 diabetes or diabetic ketoacidosis.
-
Inform your doctor if you have kidney, liver, or heart problems.
-
Stay hydrated as dapagliflozin may cause increased urination.
-
May increase risk of urinary tract and genital infections.
-
Use cautiously in pregnancy and breastfeeding.
-
Regularly monitor blood sugar, kidney function, and HbA1c.
Side Effects:
-
Urinary tract infections, genital infections
-
Headache, sore throat, stuffy nose
-
Increased urination, dehydration
-
Low blood sugar (especially with insulin or sulfonylureas)
-
Nausea, stomach pain
-
Rarely, pancreatitis or allergic reactions
Oxra S 5mg/100mg Tablet is a combination medicine containing Dapagliflozin (5mg) and Sitagliptin (100mg), prescribed for the treatment of type 2 diabetes mellitus. It helps in lowering blood glucose levels when lifestyle changes and single-drug therapy are not enough.
-
Dapagliflozin is an SGLT2 inhibitor that helps the kidneys remove excess glucose from the blood through urine.
-
Sitagliptin is a DPP-4 inhibitor that enhances incretin activity, leading to increased insulin release and decreased sugar production by the liver.
Together, they provide better blood sugar control and may also reduce risks of heart and kidney complications in diabetes.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps in achieving better control of blood sugar when monotherapy is insufficient
-
May reduce risk of cardiovascular and kidney-related complications in diabetic patients
How to Use:
Take the tablet once daily or as directed by your doctor. Swallow whole with water, with or without food. Follow a proper diet and exercise plan along with medication.
Dosage:
The dose is decided by your doctor based on your blood sugar levels and medical condition. Do not self-adjust the dose or discontinue suddenly.
Precautions:
-
Not recommended in type 1 diabetes or diabetic ketoacidosis.
-
Inform your doctor if you have kidney, liver, or heart disease.
-
May increase risk of urinary and genital infections; maintain good personal hygiene.
-
Stay well hydrated to avoid dehydration.
-
Use with caution during pregnancy and breastfeeding.
-
Monitor blood sugar and kidney function regularly.
Side Effects:
-
Urinary tract infections, genital infections
-
Increased urination, dehydration
-
Headache, sore throat, nasal congestion
-
Nausea, stomach upset
-
Low blood sugar when combined with insulin or other anti-diabetics
-
Rarely, pancreatitis or allergic reactions
Oxramet 5mg/1000mg Tablet IR is a combination of Dapagliflozin (5mg) and Metformin (1000mg), used in the management of type 2 diabetes mellitus. This dual therapy helps control blood sugar levels more effectively when diet, exercise, and single-drug therapy are not enough.
-
Dapagliflozin is an SGLT2 inhibitor that helps the kidneys eliminate excess glucose through urine, thereby lowering blood sugar.
-
Metformin is a biguanide that reduces glucose production in the liver and improves insulin sensitivity, helping the body use insulin more effectively.
Together, they provide stronger blood sugar control and may also reduce the risk of cardiovascular and kidney complications related to diabetes.
Uses:
-
Treatment of type 2 diabetes mellitus
-
Helps reduce blood sugar when single therapy is inadequate
-
May support weight management and improve heart & kidney outcomes in diabetic patients
How to Use:
Take the tablet with meals to minimize stomach upset, exactly as prescribed by your doctor. Swallow whole with water. Continue diet control and regular exercise along with the medication.
Dosage:
The dosage is tailored by your doctor depending on your blood sugar levels, response to treatment, and overall health. Do not skip or stop the medicine without medical advice.
Precautions:
-
Not recommended in type 1 diabetes or diabetic ketoacidosis.
-
Inform your doctor if you have kidney, liver, or heart disease.
-
Metformin may cause lactic acidosis (rare but serious); report symptoms like muscle pain, breathing trouble, or severe weakness immediately.
-
Dapagliflozin may increase the risk of urinary tract and genital infections.
-
Stay hydrated to prevent dehydration.
-
Use cautiously in pregnancy and breastfeeding.
-
Regular monitoring of blood sugar, kidney function, and vitamin B12 levels is advised.
Side Effects:
-
Nausea, vomiting, diarrhea, stomach upset (due to Metformin)
-
Increased urination, urinary tract infections, genital infections (due to Dapagliflozin)
-
Low blood sugar when used with insulin or sulfonylureas
-
Dizziness, dehydration
-
Rare: lactic acidosis, severe allergic reactions
Oxramet 5mg/1000mg Tablet IR is a combination medicine containing Dapagliflozin (5mg) and Metformin (1000mg), prescribed for the management of type 2 diabetes mellitus. It helps in lowering high blood sugar levels, especially in patients where diet, exercise, and single-drug therapy are insufficient.
-
Dapagliflozin (SGLT2 inhibitor) works by removing excess glucose from the body through urine.
-
Metformin (biguanide) decreases glucose production in the liver and improves the body’s response to insulin.
This combination helps achieve better blood sugar control, reduces the risk of diabetes-related complications, and may also support weight management and heart protection.
Uses:
-
Management of type 2 diabetes mellitus
-
Helps improve blood sugar control when monotherapy is inadequate
-
May lower the risk of cardiovascular and kidney complications in diabetic patients
How to Use:
Take the tablet with meals to reduce stomach discomfort. Swallow it whole with water. Follow your doctor’s advice regarding diet and exercise along with this medicine.
Dosage:
Dosage is individualized depending on your blood sugar levels, response, and overall health. Do not miss doses or stop treatment without consulting your doctor.
Precautions:
-
Not suitable for type 1 diabetes or diabetic ketoacidosis.
-
Inform your doctor if you have kidney, liver, or heart problems.
-
Metformin may rarely cause lactic acidosis; seek medical attention if you experience unexplained muscle pain, shortness of breath, or severe weakness.
-
Dapagliflozin may increase the risk of urinary tract or genital infections.
-
Maintain proper hydration to avoid dehydration.
-
Use cautiously during pregnancy and breastfeeding.
-
Regular monitoring of blood sugar, kidney function, and vitamin B12 levels is recommended.
Side Effects:
-
Nausea, vomiting, diarrhea, stomach upset (Metformin-related)
-
Increased urination, urinary tract infections, genital infections (Dapagliflozin-related)
-
Low blood sugar when taken with insulin or sulfonylureas
-
Dizziness, dehydration
-
Rare but serious: lactic acidosis, severe allergic reactions
